Clinical Trial Update: Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A neoadjuvant treatment approach guided by response is being studied in HER2-positive breast cancer across Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Thomas Hatschek | Conditions: Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING